# Monitoring Intelligence Gap Analysis

## 1. Overview
This analysis isolates pure knowledge gaps remaining within the Vilo OS Monitoring Intelligence layer, specifically avoiding duplication of previously established "Site Defense" logic. These gaps represent domains where the engine cannot currently mount a proactive defense due to missing variables or integrations.

## 2. Gaps by Category

### Query Intelligence
**Gap:** *External EDC Cross-Firing Logic*
- **Why missing:** VIP knows what generates a query conceptually, but lacks the exact validation logic (edit checks) programmed into third-party EDCs (e.g., Medidata Rave Custom Functions).
- **Operational impact:** VIP might approve a data point locally that the EDC later rejects due to a hidden cross-form logic check.
- **Risk if not learned:** False sense of security; queries still generated post-export.
- **Priority:** CRITICAL

### Finding Intelligence
**Gap:** *Investigator Site File (ISF) / eTMF Synchronization*
- **Why missing:** Current intelligence focuses on patient-level data (eCRF, Labs). It lacks awareness of site-level regulatory binders (1572s, Financial Disclosures).
- **Operational impact:** CRAs will still generate major findings during Regulatory File Review, even if patient data is perfect.
- **Risk if not learned:** FDA 483 for inadequate regulatory maintenance.
- **Priority:** HIGH

### Trend Intelligence
**Gap:** *Multi-Study / Pan-Site Trending*
- **Why missing:** VIP evaluates trends within the vacuum of a single protocol.
- **Operational impact:** A CRC making 5 errors on Study A and 5 errors on Study B is failing systemically, but VIP only sees 5 errors per study (below the threshold for a major alert).
- **Risk if not learned:** Human resource burnout and systemic site collapse goes undetected by management.
- **Priority:** HIGH

### CAPA Intelligence
**Gap:** *Sponsor-Specific CAPA Formats*
- **Why missing:** VIP knows the "5 Whys" methodology, but every CRO/Sponsor uses proprietary CAPA documentation templates with differing thresholds of acceptable evidence.
- **Operational impact:** Site creates a structurally perfect CAPA that the CRO rejects for not fitting their template.
- **Risk if not learned:** Extended CAPA negotiation delays, frustrating site staff and Sponsor QA.
- **Priority:** MEDIUM

### Audit Readiness
**Gap:** *Investigator Interview Simulation*
- **Why missing:** VIP checks documents for ALCOA+ readiness, but the FDA also conducts verbal interviews with the PI. VIP cannot assess PI verbal preparedness or deep protocol knowledge.
- **Operational impact:** A perfectly documented site can still fail an audit if the PI cannot articulate oversight mechanisms during the interview.
- **Risk if not learned:** Subjective FDA findings ("PI lacked sufficient knowledge of IP storage").
- **Priority:** MEDIUM

### Revenue Protection
**Gap:** *Invisible Contractual Penalties (Holdbacks)*
- **Why missing:** VIP lacks parsing ability for non-standard Clinical Trial Agreements (CTAs). Some sponsors silently hold back 10-20% of ALL payments until database lock, completely decoupled from operational performance.
- **Operational impact:** VIP projects 100% revenue realization for perfect compliance, while actual cash flow is 80%.
- **Risk if not learned:** Severe financial misforecasting by Site Directors.
- **Priority:** CRITICAL

### Coordinator Burden
**Gap:** *Time-Motion Quantification*
- **Why missing:** VIP tracks "tasks", but lacks baseline metrics for the *time* it takes a human to complete them (e.g., resolving a safety query takes 45 mins, a typo query takes 2 mins).
- **Operational impact:** Cannot accurately predict when a coordinator is mathematically out of hours in a week.
- **Risk if not learned:** Severe coordinator burnout, leading directly to mass data errors (the root cause of most findings).
- **Priority:** HIGH

### Sponsor Confidence Risk
**Gap:** *Communication Latency Tracking*
- **Why missing:** VIP monitors data aging, but not communication responsiveness (e.g., how fast the PI responds to the Medical Monitor's emails).
- **Operational impact:** A site with perfect data but terrible email responsiveness is still flagged as "High Risk" by Sponsor Relationship Managers.
- **Risk if not learned:** Site is secretly blacklisted from future trials despite good clinical performance.
- **Priority:** HIGH
